Respiratory Devices Market to Reach US$ 49.90 Billion by 2033 at 8.8% CAGR; Rising Chronic Respiratory Diseases and Homecare Demand Drive Growth

The global Respiratory Devices Market reached US$ 23.45 billion in 2024 and is expected to reach US$ 49.90 billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033. Market growth is driven by the rising prevalence of chronic respiratory diseases, increasing demand for long-term respiratory care, and the growing shift toward home-based and remote healthcare solutions.

Respiratory devices are medical instruments designed to support or restore normal lung function and protect users from airborne hazards by facilitating oxygen delivery and carbon dioxide removal. These devices play a critical role in the management of conditions such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and other respiratory disorders. Aging populations, heightened awareness of respiratory health, and continuous technological advancements are accelerating market adoption. Leading companies, including Fisher & Paykel Healthcare Limited, ResMed, Koninklijke Philips N.V., GE HealthCare, and Medtronic, are actively driving innovation through advanced ventilation, oxygen therapy, and sleep apnea systems. Recent regulatory approvals of next-generation therapies for obstructive sleep apnea further highlight the industry's focus on improving patient outcomes and expanding treatment options, strengthening the long-term outlook of the respiratory devices market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/respiratory-devices-market?sai-v

The Respiratory Devices Market refers to the global industry involved in the development and commercialization of medical devices used to diagnose, treat, and manage respiratory disorders.

Key Developments
✅ January 2026: In North America, demand increased for AI-assisted ventilators and smart respiratory monitoring systems in intensive care units to improve patient outcomes.

✅ December 2025: In Europe, hospitals expanded adoption of portable oxygen concentrators and home respiratory support devices to meet growing chronic respiratory disease management needs.

✅ November 2025: In Asia-Pacific, clinical facilities reported higher utilization of advanced nebulizers with precision aerosol delivery for pediatric and elderly patients.

✅ October 2025: In Latin America, respiratory therapists accelerated integration of wearable breathing monitors for early detection of pulmonary function decline.

✅ September 2025: In Middle East, healthcare providers increased deployment of sleep apnea diagnostic devices and CPAP systems to address rising obstructive sleep apnea prevalence.

✅ August 2025: In Africa, adoption of low-cost, rugged respiratory support devices increased in community clinics to improve access in rural and resource-limited settings.

Mergers & Acquisitions
✅ January 2026: In North America, a major medical technology company acquired a smart ventilator and respiratory AI-software startup to strengthen its critical care and remote monitoring portfolio.

✅ December 2025: In Europe, a leading respiratory device manufacturer acquired a precision oxygen delivery technology firm to expand its offerings for chronic respiratory disease management.

✅ November 2025: In Asia-Pacific, a regional healthcare equipment group acquired a home respiratory support devices business to enhance market penetration in emerging hospital and home care segments.

Key Players
ResMed | Koninklijke Philips N.V. | Medtronic | Fisher and Paykel Healthcare Limited | Drägerwerk AG and Co. KGaA | Getinge | Masimo | Baxter | Invacare International Holdings Corp. | CorVent Medical Inc. | AstraZeneca

Key Highlights
ResMed - Holds 21.9% share, driven by leadership in sleep apnea and non-invasive ventilation devices, strong digital health integration, and wide global adoption.

Koninklijke Philips N.V. - Holds 18.4% share, supported by a broad respiratory care portfolio including ventilators and sleep therapy devices, and strong hospital penetration.

Medtronic - Holds 15.7% share, leveraging advanced ventilatory support systems, critical care solutions, and a strong global distribution network.

Fisher and Paykel Healthcare Limited - Holds 12.6% share, driven by expertise in humidification and respiratory support devices, with strong demand in intensive care and neonatal care.

Drägerwerk AG and Co. KGaA - Holds 10.8% share, supported by high-quality ventilators, anesthesia systems, and strong presence in acute care settings.

Getinge - Holds 7.4% share, benefiting from critical care ventilation solutions and integrated hospital respiratory systems.

Masimo - Holds 5.9% share, focused on non-invasive respiratory monitoring, pulse oximetry, and advanced patient monitoring technologies.

Baxter - Holds 4.2% share, leveraging respiratory care and critical care device integration within hospital environments.

Invacare International Holdings Corp. - Holds 2.7% share, driven by home healthcare respiratory devices including oxygen concentrators and mobility-support solutions.

CorVent Medical Inc. - Holds 1.9% share, focused on emergency and portable ventilator solutions for acute respiratory care.

AstraZeneca - Holds 1.5% share, contributing through respiratory disease management solutions and device-assisted drug delivery systems.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=respiratory-devices-market?sai-v
(Purchase 2 or more Reports and get 50% Discount)

Market Drivers
- Rising prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea increasing demand for respiratory care devices.

- Growing aging population globally leading to higher incidence of respiratory disorders and long-term oxygen therapy requirements.

- Increasing adoption of home healthcare and remote patient monitoring solutions supporting use of portable respiratory devices.

- Rising air pollution levels and smoking rates contributing to higher respiratory disease burden worldwide.

- Technological advancements in respiratory devices improving portability, patient comfort, and treatment efficiency.

Industry Developments
- Continuous innovation in ventilators, oxygen concentrators, nebulizers, and CPAP/BiPAP devices with enhanced performance and usability.

- Integration of digital health technologies, connectivity, and data analytics into respiratory devices for remote monitoring and therapy management.

- Expansion of manufacturing capacity and supply chains to meet rising global demand across hospitals and homecare settings.

- Strategic collaborations between device manufacturers and healthcare providers to expand product reach and clinical adoption.

- Increased focus on compact, energy-efficient, and user-friendly respiratory devices for home and ambulatory care applications.

Regional Insights
North America - 34% share: "Driven by high prevalence of respiratory disorders, advanced healthcare infrastructure, strong reimbursement support, and widespread adoption of home respiratory care devices."

Europe - 27% share: "Supported by established pulmonary care systems, rising adoption of sleep apnea devices, and strong regulatory standards for respiratory therapy."

Asia Pacific - 31% share: "Fueled by increasing air pollution, growing patient population, expanding healthcare infrastructure, and rising demand for affordable respiratory devices."

Latin America - 5% share: "Driven by improving access to respiratory care, expansion of hospital infrastructure, and increasing awareness of chronic respiratory diseases."

Middle East & Africa - 3% share: "Supported by healthcare infrastructure development, rising respiratory disease incidence, and increasing investments in critical care facilities."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/respiratory-devices-market?sai-v

Key Segments

By Product Type
Therapeutic devices dominate the market, driven by high demand for respiratory support and treatment solutions across acute and chronic care settings. Monitoring devices hold a significant share, supported by increasing need for continuous patient monitoring and early detection of respiratory conditions. Diagnostic devices contribute notably through pulmonary function testing and imaging-based assessments. Consumables and accessories account for a substantial portion, driven by recurring demand for masks, tubing, filters, and disposables. Other products support specialized and emerging respiratory care applications.

By Application/Indication
Chronic obstructive pulmonary disease represents the leading application segment, driven by high disease prevalence and long-term management needs. Asthma holds a significant share, supported by widespread adoption of inhalation therapies and monitoring devices. Sleep apnea is growing steadily, driven by rising diagnosis rates and increased use of CPAP and related devices. Pneumonia applications contribute notably due to hospital-based respiratory care demand. Cystic fibrosis represents a specialized but important segment, supported by advanced therapeutic interventions. Bronchitis and other respiratory conditions further support overall market growth.

By Portability
Stationary devices account for a substantial share, driven by their use in hospitals, intensive care units, and long-term care facilities. Portable devices are witnessing rapid growth, supported by increasing adoption of home-based care, ambulatory monitoring, and demand for convenient, patient-friendly respiratory solutions.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.